POWI posts
FeedPosted Mar 16th 2009 12:05PM by Eric Buscemi (RSS feed)
Filed under: Analyst reports, Analyst upgrades and downgrades, Exxon Mobil (XOM), JPMorgan Chase (JPM), Sprint Nextel Corp (S), Whole Foods Market (WFMI), Coca-Cola Enterprises (CCE), Newell Rubbermaid (NWL), Analyst initiations, SanDisk Corp (SNDK)
Analyst upgrades:
- KeyBanc upgraded Greenbrier (NYSE: GBX) to Buy from Hold as it believes the company has options to forestall covenant violations or bankruptcy, event if conditions deteriorate further.
- Friedman Billings upgraded Whole Foods (NASDAQ: WFMI) to Market Perform from Underperform citing low expectations, favorable FTC settlement, progress on cost cutting, and valuation.
- JP Morgan believes First Merit (NASDAQ: FMER) is one of the best positioned Midwest banks to weather the storm and notes its compelling valuation and capital levels. The firm upgraded shares to Overweight from Neutral.
- Coca-Cola Enterprises (NYSE: CCE) was raised to Buy from Neutral at Goldman.
- Newell Rubbermaid (NYSE: NWL) was upgraded to Buy from Neutral at Banc of America/Merrill.
- Compass Minerals (NYSE: CMP) was lifted to Outperform from Perform at Oppenheimer.
Continue reading Analyst upgrades, downgrades and initiations: WFMI, CCE, S, XOM, JPM ...
Posted Feb 5th 2009 11:45AM by Eric Buscemi (RSS feed)
Filed under: Analyst reports, Analyst upgrades and downgrades, Dell (DELL), Chubb Corp (CB), Analyst initiations, Akamai Technologies (AKAM), Marvell Technology Group (MRVL)
Analyst upgrades:
- Citigroup upgraded shares of Akamai (NASDAQ: AKAM) to Buy from Hold following the company's Q4 results as they believe fundamentals are stabilizing. The firm raised their target price to $22 from $12.
- Baird upgraded Theravance (NASDAQ: THRX) to Outperform from Neutral. The firm said the company looks poised to realize the two-product success necessary to drive profitability, and Horizon will likely play a role in succeeding $7B+ Advair. Note that last night Theravance/Glaxo (GSK) reported positive results for Horizon.
- RBC Capital said Aeterna Zentaris (NASDAQ: AEZS) is on the cusp of a Cetrorelix deal and has turned more positive on shares. Shares were upgraded to Outperform from Sector Perform.
- Marvell Tech (NASDAQ: MRVL) was upgraded to Buy from Neutral at Goldman and added to the firm's Conviction Buy List.
- Sangamo BioSciences (NASDAQ: SGMO) was raised to Buy from Neutral at Merriman.
- Arthur J. Gallagher (NYSE: AJG) was upgraded at Piper Jaffray to Buy from Neutral.
Continue reading Analyst upgrades, downgrades and initiations: AKAM, MRVL, THRX, DELL, CRNT, TRV, AEIS ...
Posted Sep 25th 2008 11:40AM by Eric Buscemi (RSS feed)
Filed under: Analyst upgrades and downgrades, Penney (J.C.) (JCP), CBS Corp 'B' (CBS), Alcatel-LucentADS (ALU), Starwood Hotels Worldwide (HOT), Marriott Intl'A' (MAR), Analyst initiations, Lloyds TSB Group plc ADS (LYG)
Analyst upgrades:
- JMP Securities upgraded Vertex Pharma (NASDAQ: VRTX) to Outperform from Market Perform following better-than-expected interim data for telaprevir.
- Lazard Capital upgraded shares of Biogen Idec (NASDAQ: BIIB) to Buy from Hold on valuation after their physician survey indicated solid sales growth in the company's MS franchise.
- Calyon upgraded Data Domain (NASDAQ: DDUP) to Add from Neutral based on positive channel checks and valuation.
- Goldman added Buckeye GP (NYSE: BGH) to the Conviction Buy List.
- Alcatel-Lucent (NYSE: ALU) was upgraded to Hold from Sell and Ericsson (NASDAQ: ERIC) was raised to Hold from Reduce at WestLB.
- Keefe Bruyette upgraded Cowen Group (NASDAQ: COWN) to OUtperform from Market Perform.
Analyst downgrades:
- Deutsche Bank downgraded shares of Lloyds TSB Group (NYSE: LYG) to Sell from Hold as they believe loan loss risk will outweigh synergies from the acquisition of HBOS (HBOOY).
- Citigroup downgraded shares of National Financial Partners (NYSE: NFP) to Hold from Buy and removed the stock from the Top Picks Live List after the company announced July and August revenues and said pressure continues. The firm lowered their target to $20 from $28.
Continue reading Analyst calls: BIIB, ALU, LYG, MAR, HOT, JCP, MYL, CBS ...